Search results
Asthma, COPD: Trial shows benefits of diagnosing conditions early
Medical News Today· 5 days agoResearchers report that as many as 70% of people with chronic obstructive pulmonary disease (COPD)...
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...
Benzinga· 4 days agoDupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
AstraZeneca’s fasenra asthma drug shows promise for COPD treatment
BioPharma-Reporter· 4 days agoThis approval extends Fasenra's availability to over 80 countries, including the US, EU, and Japan....
NEW DATA PRESENTED AT ATS 2024 SHOW THE POTENTIAL OF TEZSPIRE® TO HELP PATIENTS LIVING WITH COPD
CBS 47 Fresno· 5 days agoThe primary results showed that treatment with Tezspire led to a 17% numerical reduction in the annual rate of moderate or severe COPD exacerbations compared ...
Results from Late-Breaking Clinical Trials on COPD | Newswise
Newswise· 4 days agoThis week at the ATS 2024 International Conference, researchers announced results from three clinical trials – the ARISE Study on amikacin liposome inhal
Lung Cancer Screening IDs Pulmonary Comorbidities
Medscape· 2 days agoA majority of individuals with no reported history of COPD showed evidence of COPD symptoms.
Asthma, COPD often not diagnosed, study indicates
UPI· 5 days agoFinding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease improved their health and led to fewer appointments for...
Community Outreach Identifies Asthma, COPD
Medscape· 4 days agoPersons with asthma or COPD found through community outreach had improvements in lung function and quality of life over 1 year in a randomized trial.
Up to 70 Percent of People With Asthma and COPD Go Undiagnosed
New York Times· 4 days agoIn spring 2020, Jazzminn Hein received an automated phone call from The Ottawa Hospital in Canada,...
Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient...
Benzinga via Yahoo Finance· 4 days agoThe primary results showed that treatment with Tezspire led to a 17% numerical reduction in the...